O	O	O	0	8	Affinity	Affinity	B-NP	NN	O	0	ROOT	O
O	O	O	8	9	-	-	B-PP	HYPH	O	1	NMOD	O
O	O	O	9	15	driven	drive	B-NP	VBN	O	5	NMOD	O
O	O	O	16	23	peptide	peptide	I-NP	NN	O	5	NMOD	O
O	O	O	24	33	selection	selection	I-NP	NN	O	2	PMOD	O
O	O	O	34	36	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	37	39	an	an	B-NP	DT	O	9	NMOD	O
T1	B-Entity	B-Entity	40	44	NFAT	NFAT	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	45	54	inhibitor	inhibitor	I-NP	NN	O	6	PMOD	O
O	O	O	55	59	more	more	B-ADJP	RBR	O	11	AMOD	O
O	O	O	60	69	selective	selective	I-ADJP	JJ	O	5	NMOD	O
O	O	O	70	74	than	than	B-PP	IN	O	11	AMOD	O
O	O	O	75	86	cyclosporin	cyclosporin	B-NP	NN	O	14	NMOD	O
O	O	O	87	88	A	A	I-NP	NN	O	12	PMOD	O
O	O	O	89	90	[	[	O	(	O	16	VMOD	O
O	O	O	90	93	see	see	B-VP	VB	O	1	NMOD	O
O	O	O	94	102	comments	comment	B-NP	NNS	O	16	OBJ	O
O	O	O	102	103	]	]	O	)	O	16	VMOD	O

O	O	O	105	108	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	109	113	flow	flow	I-NP	NN	O	23	SUB	O
O	O	O	114	116	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	117	128	information	information	B-NP	NN	O	3	PMOD	O
O	O	O	129	133	from	from	B-PP	IN	O	4	NMOD	O
O	O	O	134	141	calcium	calcium	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	141	142	-	-	B-ADVP	HYPH	I-protein	9	P	I-protein
O	O	O	142	152	mobilizing	mobilize	B-VP	VBG	I-protein	9	NMOD	I-protein
O	O	O	153	162	receptors	receptor	B-NP	NNS	I-protein	5	PMOD	I-protein
O	O	O	163	165	to	to	B-PP	TO	O	4	NMOD	O
T2,T3	B-Entity,B-Entity	B-Entity,B-Entity	166	173	nuclear	nuclear	B-NP	JJ	B-protein	16	NMOD	B-protein
T2,T3	I-Entity,I-Entity	I-Entity,I-Entity	174	180	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T2,T3	I-Entity,I-Entity	I-Entity,I-Entity	181	183	of	of	B-PP	IN	I-protein	16	NMOD	I-protein
T2,T3	I-Entity,I-Entity	I-Entity,I-Entity	184	193	activated	activate	B-NP	VBN	I-protein	16	NMOD	I-protein
T2,T3	I-Entity,I-Entity	I-Entity,I-Entity	194	195	T	T	I-NP	NN	I-protein	16	NMOD	I-protein
T2,T3	I-Entity	I-Entity	196	201	cells	cell	I-NP	NNS	I-protein	22	NMOD	I-protein
T2	I-Entity	I-Entity	202	203	(	(	O	(	O	19	DEP	O
T2,T4	I-Entity,B-Entity	I-Entity,B-Entity	203	207	NFAT	NFAT	B-NP	NN	B-protein	19	DEP	B-protein
T2	I-Entity	I-Entity	207	208	)	)	O	)	O	16	NMOD	O
T2	I-Entity	I-Entity	208	209	-	-	B-NP	HYPH	O	16	P	O
T2	I-Entity	I-Entity	209	218	dependent	dependent	I-NP	JJ	O	22	NMOD	O
T2	I-Entity	I-Entity	219	224	genes	gene	I-NP	NNS	O	10	PMOD	O
O	O	O	225	227	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	228	238	critically	critically	B-ADJP	RB	O	23	VMOD	O
O	O	O	239	248	dependent	dependent	I-ADJP	JJ	O	23	PRD	O
O	O	O	249	251	on	on	B-PP	IN	O	25	AMOD	O
O	O	O	252	263	interaction	interaction	B-NP	NN	O	26	PMOD	O
O	O	O	264	271	between	between	B-PP	IN	O	27	NMOD	O
O	O	O	272	275	the	the	B-NP	DT	O	31	NMOD	O
T5	B-Entity	B-Entity	276	287	phosphatase	phosphatase	I-NP	NN	B-protein	31	NMOD	B-protein
T5	I-Entity	I-Entity	288	299	calcineurin	calcineurin	I-NP	NN	B-protein	36	NMOD	B-protein
O	O	O	300	303	and	and	O	CC	O	36	NMOD	O
O	O	O	304	307	the	the	B-NP	DT	O	36	NMOD	O
T6	B-Entity	B-Entity	308	321	transcription	transcription	I-NP	NN	B-protein	36	NMOD	B-protein
T6	I-Entity	I-Entity	322	328	factor	factor	I-NP	NN	I-protein	36	NMOD	I-protein
T6	I-Entity	I-Entity	329	333	NFAT	NFAT	I-NP	NN	B-protein	28	PMOD	B-protein
O	O	O	333	334	.	.	O	.	O	23	P	O

O	O	O	335	336	A	A	B-NP	DT	O	8	NMOD	O
T7	B-Entity	B-Entity	337	341	high	high	I-NP	JJ	O	8	NMOD	O
T7	I-Entity	I-Entity	341	342	-	-	I-NP	HYPH	O	8	NMOD	O
T7	I-Entity	I-Entity	342	350	affinity	affinity	I-NP	NN	O	8	NMOD	O
T7,T8	I-Entity,B-Entity	I-Entity,B-Entity	351	362	calcineurin	calcineurin	I-NP	NN	B-protein	8	NMOD	B-protein
T7	I-Entity	I-Entity	362	363	-	-	O	HYPH	O	8	NMOD	O
T7	I-Entity	I-Entity	363	370	binding	bind	B-NP	VBG	O	8	NMOD	O
T7	I-Entity	I-Entity	371	378	peptide	peptide	I-NP	NN	O	9	SUB	O
O	O	O	379	382	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	383	391	selected	select	I-VP	VBN	O	9	VC	O
O	O	O	392	396	from	from	B-PP	IN	O	10	VMOD	O
O	O	O	397	410	combinatorial	combinatorial	B-NP	JJ	O	14	NMOD	O
T9	B-Entity	B-Entity	411	418	peptide	peptide	I-NP	NN	O	14	NMOD	O
T9	I-Entity	I-Entity	419	428	libraries	library	I-NP	NNS	O	11	PMOD	O
O	O	O	429	434	based	base	B-PP	VBN	O	14	NMOD	O
O	O	O	435	437	on	on	B-PP	IN	O	15	PMOD	O
O	O	O	438	441	the	the	B-NP	DT	O	20	NMOD	O
T10,T11	B-Entity,B-Entity	B-Entity,B-Entity	442	453	calcineurin	calcineurin	I-NP	NN	B-protein	20	NMOD	B-protein
T10	I-Entity	I-Entity	454	461	docking	docking	I-NP	NN	I-protein	20	NMOD	I-protein
T10	I-Entity	I-Entity	462	467	motif	motif	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	O	468	470	of	of	B-PP	IN	O	20	NMOD	O
T12	B-Entity	B-Entity	471	475	NFAT	NFAT	B-NP	NN	B-protein	21	PMOD	B-protein
O	O	O	475	476	.	.	O	.	O	9	P	O

O	O	O	477	481	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	482	489	peptide	peptide	I-NP	NN	O	4	SUB	O
O	O	O	490	498	potently	potently	B-ADVP	RB	O	4	VMOD	O
O	O	O	499	508	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
T13	B-Entity	B-Entity	509	513	NFAT	NFAT	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	514	524	activation	activation	I-NP	NN	O	11	NMOD	O
O	O	O	525	528	and	and	O	CC	O	11	NMOD	O
T14	B-Entity	B-Entity	529	533	NFAT	NFAT	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	533	534	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	O	534	543	dependent	dependent	I-NP	JJ	O	11	NMOD	O
O	O	O	544	554	expression	expression	I-NP	NN	O	4	OBJ	O
O	O	O	555	557	of	of	B-PP	IN	O	11	NMOD	O
T15	B-Entity	B-Entity	558	568	endogenous	endogenous	B-NP	JJ	B-DNA	15	NMOD	B-DNA
T15	I-Entity	I-Entity	569	577	cytokine	cytokine	I-NP	NN	I-DNA	15	NMOD	I-DNA
T15	I-Entity	I-Entity	578	583	genes	gene	I-NP	NNS	I-DNA	12	PMOD	I-DNA
O	O	O	584	586	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	587	588	T	T	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	O	589	594	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	O	594	595	,	,	O	,	O	4	P	O
O	O	O	596	603	without	without	B-PP	IN	O	4	VMOD	O
O	O	O	604	613	affecting	affect	B-VP	VBG	O	20	PMOD	O
O	O	O	614	617	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	618	628	expression	expression	I-NP	NN	O	21	OBJ	O
O	O	O	629	631	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	632	637	other	other	B-NP	JJ	O	26	NMOD	O
O	O	O	638	647	cytokines	cytokine	I-NP	NNS	B-protein	24	PMOD	B-protein
O	O	O	648	652	that	that	B-NP	WDT	O	26	NMOD	O
O	O	O	653	660	require	require	B-VP	VBP	O	27	SBAR	O
T16	B-Entity	B-Entity	661	672	calcineurin	calcineurin	B-NP	NN	B-protein	28	OBJ	B-protein
O	O	O	673	676	but	but	B-NP	CC	O	32	NMOD	O
O	O	O	677	680	not	not	I-NP	RB	O	30	DEP	O
T17	B-Entity	B-Entity	681	685	NFAT	NFAT	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	O	685	686	.	.	O	.	O	4	P	O

O	O	O	687	699	Substitution	Substitution	B-NP	NN	O	13	SUB	O
O	O	O	700	702	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	703	706	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	707	716	optimized	optimize	I-NP	VBN	O	6	NMOD	O
T18	B-Entity	B-Entity	717	724	peptide	peptide	I-NP	NN	O	6	NMOD	O
T18	I-Entity	I-Entity	725	733	sequence	sequence	I-NP	NN	O	2	PMOD	O
O	O	O	734	738	into	into	B-PP	IN	O	1	NMOD	O
O	O	O	739	742	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	743	750	natural	natural	I-NP	JJ	O	12	NMOD	O
T19,T20	B-Entity,B-Entity	B-Entity,B-Entity	751	762	calcineurin	calcineurin	I-NP	NN	B-protein	12	NMOD	B-protein
T19	I-Entity	I-Entity	763	770	docking	docking	I-NP	NN	I-protein	12	NMOD	I-protein
T19	I-Entity	I-Entity	771	775	site	site	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	776	785	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	O	786	789	the	the	B-NP	DT	O	16	NMOD	O
T21	B-Entity	B-Entity	790	801	calcineurin	calcineurin	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	802	816	responsiveness	responsiveness	I-NP	NN	O	13	OBJ	O
O	O	O	817	819	of	of	B-PP	IN	O	16	NMOD	O
T22	B-Entity	B-Entity	820	824	NFAT	NFAT	B-NP	NN	B-protein	17	PMOD	B-protein
O	O	O	824	825	.	.	O	.	O	13	P	O

O	O	O	826	835	Compounds	Compound	B-NP	NNS	O	16	SUB	O
O	O	O	836	840	that	that	B-NP	WDT	O	1	NMOD	O
O	O	O	841	850	interfere	interfere	B-VP	VBP	O	2	SBAR	O
O	O	O	851	862	selectively	selectively	B-ADVP	RB	O	3	VMOD	O
O	O	O	863	867	with	with	B-PP	IN	O	3	VMOD	O
O	O	O	868	871	the	the	B-NP	DT	O	10	NMOD	O
T23	B-Entity	B-Entity	872	883	calcineurin	calcineurin	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	883	884	-	-	B-NP	HYPH	O	10	NMOD	O
T24	B-Entity	B-Entity	884	888	NFAT	NFAT	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	889	900	interaction	interaction	I-NP	NN	O	5	PMOD	O
O	O	O	901	908	without	without	B-PP	IN	O	3	VMOD	O
O	O	O	909	918	affecting	affect	B-VP	VBG	O	11	PMOD	O
T25	B-Entity	B-Entity	919	930	calcineurin	calcineurin	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	931	942	phosphatase	phosphatase	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	943	951	activity	activity	I-NP	NN	O	12	OBJ	O
O	O	O	952	955	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	956	958	be	be	I-VP	VB	O	16	VC	O
O	O	O	959	965	useful	useful	B-ADJP	JJ	O	17	PRD	O
O	O	O	966	968	as	as	B-SBAR	IN	O	16	VMOD	O
O	O	O	969	980	therapeutic	therapeutic	B-NP	JJ	O	21	NMOD	O
O	O	O	981	987	agents	agent	I-NP	NNS	O	19	PMOD	O
O	O	O	988	992	that	that	B-NP	WDT	O	21	NMOD	O
O	O	O	993	996	are	be	B-VP	VBP	O	22	SBAR	O
O	O	O	997	1001	less	less	B-ADJP	RBR	O	25	AMOD	O
O	O	O	1002	1007	toxic	toxic	I-ADJP	JJ	O	23	PRD	O
O	O	O	1008	1012	than	than	B-PP	IN	O	25	AMOD	O
O	O	O	1013	1020	current	current	B-NP	JJ	O	28	NMOD	O
O	O	O	1021	1026	drugs	drug	I-NP	NNS	O	26	PMOD	O
O	O	O	1026	1027	.	.	O	.	O	16	P	O
